Cour Pharmaceutical Development Company, Inc.

This study tested an experimental drug called CNP-104 in adults with primary biliary cholangitis (PBC), a liver disease, who were not responding well to their current medications. The main goals were to see if the drug was safe and if it could help control the disease by reducing…